The DOI matches its Crossref record.
Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections
Abstract
Endolysins are the lytic products of bacteriophage, which play a specific role in the release of phage progeny by degrading the peptidoglycan of host bacterium. In the light of antibiotic resistance, endolysins are being considered as an alternative therapeutic agent because of their exceptional ability to target bacterial cells when applied externally. Endolysins have been explored against a number of drug resistant pathogens to assess their therapeutic ability. Present review focuses on the endolysin structure in terms of cell binding and catalytic domains, lytic ability, resistance, safety, immunogenicity and future applications. It primarily reviews the recent advancements made in the evaluation of therapeutic potential of endolysins, including their origin, host range, applications and synergy with conventional and non conventional antimicrobial agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Current Treatment Strategies Against Multidrug-Resistant Bacteria: A Review
Parmanik, A., Das, S., Kar, B., Bose, A., Dwivedi, G. R., & Pandey, M. M. (2022) · Current Microbiology · doi:10.1007/s00284-022-03061-7 · Cited by 277
The applications of animal models in phage therapy: An update
Mehmood Khan, F., Manohar, P., Singh Gondil, V., Mehra, N., Kayode Oyejobi, G., Odiwuor, N., Ahmad, T., & Huang, G. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2175519 · Cited by 32
Bacteriophage Bioengineering: A Transformative Approach for Targeted Drug Discovery and Beyond
Cui, L., Veeranarayanan, S., Thitiananpakorn, K., & Wannigama, D. L. (2023) · Pathogens · doi:10.3390/pathogens12091179 · Cited by 16
Metadata
- Authors
- Gondil, V. S., Harjai, K., & Chhibber, S.
- Venue
- International Journal of Antimicrobial Agents
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 55
- Issue
- 2
- Pages
- 105844
- ISSN
- 0924-8579 (ISSN-L)
- OpenAlex
- W2986623887
- Cited by
- 173
- References
- 0
- FWCI
- 10.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections. https://app.cochat.ai/papers/10.1016/j.ijantimicag.2019.11.001
- The paper
- Gondil, V. S., Harjai, K., & Chhibber, S. (2020). Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections. International Journal of Antimicrobial Agents. https://doi.org/10.1016/j.ijantimicag.2019.11.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.